Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD).
Publication
, Journal Article
Shuren, J; Doraiswamy, PM
Published in: J Prev Alzheimers Dis
2022
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Prev Alzheimers Dis
DOI
EISSN
2426-0266
Publication Date
2022
Volume
9
Issue
2
Start / End Page
236 / 240
Location
Switzerland
Related Subject Headings
- Humans
- Alzheimer Disease
- 5204 Cognitive and computational psychology
- 5202 Biological psychology
- 3209 Neurosciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Shuren, J., & Doraiswamy, P. M. (2022). Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD). J Prev Alzheimers Dis, 9(2), 236–240. https://doi.org/10.14283/jpad.2022.28
Shuren, J., and P. M. Doraiswamy. “Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD).” J Prev Alzheimers Dis 9, no. 2 (2022): 236–40. https://doi.org/10.14283/jpad.2022.28.
Shuren J, Doraiswamy PM. Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD). J Prev Alzheimers Dis. 2022;9(2):236–40.
Shuren, J., and P. M. Doraiswamy. “Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD).” J Prev Alzheimers Dis, vol. 9, no. 2, 2022, pp. 236–40. Pubmed, doi:10.14283/jpad.2022.28.
Shuren J, Doraiswamy PM. Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective - Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD). J Prev Alzheimers Dis. 2022;9(2):236–240.
Published In
J Prev Alzheimers Dis
DOI
EISSN
2426-0266
Publication Date
2022
Volume
9
Issue
2
Start / End Page
236 / 240
Location
Switzerland
Related Subject Headings
- Humans
- Alzheimer Disease
- 5204 Cognitive and computational psychology
- 5202 Biological psychology
- 3209 Neurosciences